IRadimed Corporation (IRMD) Research
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
Market snapshot
- Symbol
- IRMD
- Price
- $92.20
- Day change
- +1.22%
- Market cap
- $1.2B
- P/E ratio
- 49.92x
- 52-week range
- 55.109-107.9
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 1 month
- Analyst price target
- $120
Peer companies
Recent insider activity
- Scharen-Guivel Hilda Frederique — S-Sale (1766 shares) on 2026-06-04
- Scharen-Guivel Hilda Frederique — S-Sale (1234 shares) on 2026-06-04
- Susi Roger E. — S-Sale (400 shares) on 2026-06-01
- Susi Roger E. — S-Sale (775 shares) on 2026-06-01
- Susi Roger E. — S-Sale (401 shares) on 2026-06-01
Open IRadimed Corporation (IRMD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.